COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?

by Selçuk Şen, Ali Yağız Üresin
Published 2020-10-01

Losartan may prevent the elevation of plasma glucose, corticosterone and catecholamine levels induced by chronic stress

by Yağiz Üresin, Bahar Erbas, Mehmet Özek, Elif Özkök, Ali Osman Gürol
Published 2004-06-01

Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials

by Pınar Kızılırmak, Yağız Üresin, Oktay Özdemir, Burçak Kılıçkıran Avcı, Lale Tokgözoğlu, Zeki Öngen
Published 2017-01-01

Traditional Chinese medicine practices used in COVID-19 (Sars-cov 2/Coronavirus-19) treatment in clinic and their effects on the cardiovascular system

by Emine Akalın, Miraç Ekici, Zinar Alan, Elif Özbir Elevli, Aysenur Yaman Bucak, Nuerbiye Aobuliaikemu, Ali Yağız Üresin
Published 2020-06-01

Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension

by Yagiz Uresin, Addison A Taylor, Charles Kilo, Diethelm Tschöpe, Massimo Santonastaso, Ghionul Ibram, Hui Fang, Andrew Satlin
Published 2007-12-01

Legal and ethical framework for global health information and biospecimen exchange - an international perspective

by Lara Bernasconi, Selçuk Şen, Luca Angerame, Apolo P. Balyegisawa, Damien Hong Yew Hui, Maximilian Hotter, Chung Y. Hsu, Tatsuya Ito, Francisca Jörger, Wolfgang Krassnitzer, Adam T. Phillips, Rui Li, Louise Stockley, Fabian Tay, Charlotte von Heijne Widlund, Ming Wan, Creany Wong, Henry Yau, Thomas F. Hiemstra, Yagiz Uresin, Gabriela Senti
Published 2020-01-01